← Alle mensen

JC

Jane Chang

2 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

First-line talazoparib plus enzalutamide versus placebo plus enzalutamide for metastatic castration-resistant prostat...
The Lancet. Oncology · 2025-04
First-line talazoparib plus enzalutamide versus placebo plus enzalutamide in men with metastatic castration-resistant...
The Lancet. Oncology · 2025-04